Related Experiment Videos
Patent protection for microbial technologies.
1Innovation Center for Law and Technology, New York Law School, New York, NY 10013, USA.
FEMS Microbiology Letters
|October 14, 2017
Summary
Patenting microbial technologies like CRISPR, viral vectors, and antimicrobial resistance drugs involves complex ethical and legal issues. The patent system significantly impacts the scientific and commercial progress of these crucial molecular biology tools.
Area of Science:
- Molecular Biology
- Biotechnology
- Intellectual Property Law
Background:
- Microbial technologies are foundational to molecular biology research.
- Patenting these technologies raises significant ethical, legal, and social concerns.
- CRISPR, viral vectors, and antimicrobial resistance drugs are key examples.
Purpose of the Study:
- To examine the patenting landscape of essential microbial technologies.
- To analyze the ethical, legal, and social implications of these patents.
- To assess the impact of patent regimes on technological development.
Main Methods:
- Case study analysis of CRISPR, viral vectors, and antimicrobial resistance drugs.
- Review of patent law and ethical considerations.
- Commentary on the intersection of intellectual property and scientific advancement.
Main Results:
- Patenting presents multifaceted ethical, legal, and social challenges for microbial tools.
- The patent regime influences both scientific discovery and commercialization.
- Researchers' enforcement of patents affects technology accessibility and development.
Conclusions:
- The patent system is a critical factor in the advancement of microbial technologies.
- Balancing innovation with ethical considerations is essential for CRISPR, viral vectors, and antimicrobial drugs.
- Future development hinges on effective patent strategies and enforcement.